Strategically selecting the right outsourcing models can accelerate the cost and time curve of drug development by maximizing quality, operational success, and financial efficiencies. To help meet increasingly demanding timelines, organizations are looking more to functional service partnership models to outsource specific functions of clinical trials (e.g., clinical operations, pharmacovigilance, medical writing, etc.). The increasing…